相关实验视频
Updated: Sep 14, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
357
在亚洲印第安人移民中降低心血管疾病风险因素的干预措施:一个范围审查协议
Abeer M Mobarki1, Karen T D'Alonzo2, Maya E Joseph3
1School of Nursing, Rutgers The State University of New Jersey, Newark, New Jersey, USA.
BMJ open
|July 20, 2025
概括
本范围审查确定了亚洲印度移民的有效心血管疾病 (CVD) 干预措施. 它强调需要有针对性的策略来降低这一群体中高心血管疾病风险.
科学领域:
- 公共卫生 公共卫生
- 心血管疾病研究研究
- 移民健康 移民健康
背景情况:
- 亚洲印第安人 (AI) 移民的心血管疾病 (CVD) 患病率明显高于其他亚洲亚组和美国普通人口.
- 尽管已知心血管疾病风险因素,但专门为美国的AI移民社区设计的心脏保护干预措施很少.
- 这个人口代表了美国第二大移民群体,强调了解决他们的心血管疾病风险的公共卫生重要性.
研究的目的:
- 系统地识别和综合有效的干预措施,旨在降低第一代亚洲印第安人 (AI) 移民中心血管疾病 (CVD) 风险因素.
- 引导未来的研究,并为改善高风险人口群体中心血管疾病结果的实际建议提供信息.
- 建立现有干预措施及其有效性的全面概述.
主要方法:
- 一种基于Arksey和O'Malley框架和PRISMA-ScR扩展的范围审查方法.
- 系统地搜索电子数据库进行干预研究 (2000-2025),涉及第一代AI移民 (18-70岁) 有或没有心血管疾病风险因素.
- 通过两个独立审查员提取关于研究设计,参与者特征,干预措施,结果和发现的数据.
主要成果:
- 审查将确定和总结最有效的干预措施,以减少目标人群中CVD风险因素.
- 主要发现将突出成功的干预策略,当前研究的潜在差距,以及未来研究的领域.
- 将介绍基于证据的实践综合,以告知临床和社区层面的战略.
结论:
- 有效的,有针对性的干预措施对于减轻亚裔印度移民中观察到的心血管疾病风险增加至关重要.
- 这些发现将为开发和实施基于证据的心脏保护策略提供基础.
- 通过出版物,会议和社区宣传传播将促进有效干预措施的采用.
相关概念视频
01:26Coronary Artery Disease IV: Preventive Measures
36
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
36
01:26Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36
01:28Acute Coronary Syndrome IV: Interprofessional Care
30
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
30
01:27Coronary Artery Disease V: Interprofessional Care
34
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
34
01:27Peripheral Artery Disease III: Interprofessional Care
30
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
30
01:26Angina IV: Management
25
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
25